Literature DB >> 29416940

Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma.

Si Li1, Fangying Xu1, Jing Zhang1, Lili Wang1, Yang Zheng1, Xuesong Wu1, Jing Wang1, Qiong Huang1, Maode Lai1.   

Abstract

The immune contexture, a composition of the tumor microenvironment, plays multiple important roles in cancer stem cell (CSC) and epithelial-mesenchymal transition (EMT), and hence critically influences tumor initiation, progression and patient outcome. Tumor-associated macrophages (TAMs) are abundant in immune contexture, however their roles in CSC, EMT and prognosis of colorectal cancer (CRC) have not been elucidated. In 419 colorectal carcinomas, immune cell types (CD68+ macrophages, CD3+, CD4+ or CD8+ T lymphocytes, CD20+ B lymphocytes), EMT markers (E-cadherin and Snail) as well as the stem cell marker (CD44v6) were detected in tumor center (TC) and tumor invasive front (TF) respectively by immunohistochemistry. Tumor buds, that represent EMT phenotype, were also counted. It was found CD68+ macrophages were the most infiltrating immune cells in CRC. By correlation analysis, more CD68+TF macrophages were associated with more CD44v6 expression (p < 0.001), lower SnailTF expression (p = 0.08) and fewer tumor buds (p < 0.001). More CD68+TF macrophages were significantly related to more CD3+TF T lymphocytes (p = 0.002), CD8+TF T lymphocytes (p < 0.001) and CD20+TF B lymphocytes counts (p = 0.004). Strong CD68+TF macrophages infiltration also predicted long term overall survival. CRC patients with more tumor buds had worse survival. However, strong CD68+TF macrophages infiltration could reverse the unfavorable results since patients with more tumor buds but increasing CD68+TF macrophages infiltration had the favorable outcome, similar to lower tumor buds groups. This study provided direct morphological evidence that tumor-associated macrophages in the invasive front play critical roles in fighting with the unfavorable results of tumor buds, thus resulting favorable outcomes for CRC patients.

Entities:  

Keywords:  epithelial-mesenchymal transition; prognosis; stemness; tumor associated macrophages; tumor bud

Year:  2017        PMID: 29416940      PMCID: PMC5798198          DOI: 10.1080/2162402X.2017.1380765

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  39 in total

Review 1.  A decade of progress in adipose tissue macrophage biology.

Authors:  Andrea A Hill; W Reid Bolus; Alyssa H Hasty
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

2.  Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma.

Authors:  Liang Yi; Hualiang Xiao; Minhui Xu; Xianzong Ye; Jun Hu; Fei Li; Mei Li; Chunxia Luo; Shicang Yu; Xiuwu Bian; Hua Feng
Journal:  J Neuroimmunol       Date:  2010-11-05       Impact factor: 3.478

Review 3.  Cancer stem cells: an evolving concept.

Authors:  Long V Nguyen; Robert Vanner; Peter Dirks; Connie J Eaves
Journal:  Nat Rev Cancer       Date:  2012-01-12       Impact factor: 60.716

4.  High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

Authors:  Johan Forssell; Ake Oberg; Maria L Henriksson; Roger Stenling; Andreas Jung; Richard Palmqvist
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

5.  Macrophages: Good guys in colorectal cancer.

Authors:  Sofia Edin; Maria L Wikberg; Per-Arne Oldenborg; Richard Palmqvist
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110

Review 6.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

7.  An M1-like Macrophage Polarization in Decidual Tissue during Spontaneous Preterm Labor That Is Attenuated by Rosiglitazone Treatment.

Authors:  Yi Xu; Roberto Romero; Derek Miller; Leena Kadam; Tara N Mial; Olesya Plazyo; Valeria Garcia-Flores; Sonia S Hassan; Zhonghui Xu; Adi L Tarca; Sascha Drewlo; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2016-02-17       Impact factor: 5.422

8.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

Review 9.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  Oncotarget       Date:  2010-11

10.  Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.

Authors:  Wenchao Zhou; Susan Q Ke; Zhi Huang; William Flavahan; Xiaoguang Fang; Jeremy Paul; Ling Wu; Andrew E Sloan; Roger E McLendon; Xiaoxia Li; Jeremy N Rich; Shideng Bao
Journal:  Nat Cell Biol       Date:  2015-01-12       Impact factor: 28.824

View more
  27 in total

1.  Spatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patients.

Authors:  Ines P Nearchou; Bethany M Gwyther; Elena C T Georgiakakis; Christos G Gavriel; Kate Lillard; Yoshiki Kajiwara; Hideki Ueno; David J Harrison; Peter D Caie
Journal:  NPJ Digit Med       Date:  2020-05-15

Review 2.  Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site.

Authors:  Elaheh Nasrollahzadeh; Sepideh Razi; Mahsa Keshavarz-Fathi; Massimiliano Mazzone; Nima Rezaei
Journal:  Cancer Immunol Immunother       Date:  2020-06-04       Impact factor: 6.968

3.  Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study.

Authors:  Hina Qayoom; Umar Mehraj; Shazia Sofi; Shariqa Aisha; Abdullah Almilaibary; Mustfa Alkhanani; Manzoor Ahmad Mir
Journal:  Med Oncol       Date:  2022-07-23       Impact factor: 3.738

Review 4.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 5.  Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer.

Authors:  Yamei Zhao; Xiaoxu Ge; Xiaoming Xu; Shaojun Yu; Jian Wang; Lifeng Sun
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-24       Impact factor: 4.553

6.  Overexpression of 14-3-3ζ in lung tissue predicts an improved outcome in patients with lung adenocarcinoma.

Authors:  Man Li; Hailing Lu; Xiaolian Liu; Qingwei Meng; Yanbin Zhao; Xuesong Chen; Jing Hu; Wei Liu; Li Cai
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

7.  Elevated CD163+/CD68+ Ratio at Tumor Invasive Front is Closely Associated with Aggressive Phenotype and Poor Prognosis in Colorectal Cancer.

Authors:  Chaogang Yang; Chen Wei; Shuyi Wang; Dongdong Shi; Chunxiao Zhang; Xiaobin Lin; Rongzhang Dou; Bin Xiong
Journal:  Int J Biol Sci       Date:  2019-03-10       Impact factor: 6.580

8.  SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target.

Authors:  Shaokun Wang; Li Pang; Zuolong Liu; Xiangwei Meng
Journal:  BMC Cancer       Date:  2021-07-03       Impact factor: 4.430

Review 9.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.

Authors:  Łukasz Zadka; Damian J Grybowski; Piotr Dzięgiel
Journal:  Cell Oncol (Dordr)       Date:  2020-06-02       Impact factor: 6.730

Review 10.  Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.

Authors:  Liang Guo; Chuanlei Wang; Xiang Qiu; Xiaoyu Pu; Pengyu Chang
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.